The automation of insulin delivery in response to real-time sensor glucose levels reduces the need for user input, and events such as post-prandial hyperglycaemia or exercise-induced hypoglycaemia may be prevented or attenuated by the closed-loop system itself. This evidence concerns the gene INS and Hyperglycemia.